drugset / Trial / NCT01002443

Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer

NCT01002443

Phase 2 Completed 190 enrolled National Cancer Center, Korea
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Helicobacter pylori (H. pylori) is associated with gastric cancer in epidemiological studies.Gastric atrophy and intestinal metaplasia caused by H. pylori are considered as precancerous lesions, but whether H. pylori eradication improves these lesions is controversial.The primary objective of this study is to evaluate whether Helicobacter pylori eradication improves glandular atrophy and intestinal metaplasia which are known to be precancerous condition in patients undergoing subtotal gastrectomy for gastric cancer.

Timeline

Start
2003-07
Primary completion
2006-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 1000 mg
Comparator Clarithromycin Small molecule 500 mg
Comparator Omeprazole Other / unclassified 20 mg
Comparator Rabeprazole Small molecule 10 mg

Indications